The Study of Perioperative Intravenous Infusion of Lidocaine on Postoperative Analgesia in Patients Undergoing Single-port Thoracoscopic
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
The World Congress on Pain identified pain as the "fifth leading indicator of human life" after breathing, pulse, body temperature and blood pressure. Postoperative pain is an acute nociceptive pain caused by surgical trauma and is a complex stress response in the body, especially in 72 hours after surgery. Pain after thoracic surgery is a more severe type of surgery in various types of surgery.
Acute pain at the early stage of operation is not only an external signal of body injury, but also an independent factor inducing stress response and systemic inflammatory response syndrome (SIRS). Pain stimulus can also cause excessive release of catecholamine, damage of vascular endothelial cells and neutrophil aggregation, which can induce cytokine "waterfall" secretion. Stress, pain and inflammation induce and interact with each other, which seriously affects the early recovery of patients after operation. Timely and effective post-operative analgesia can not only alleviate patients'pain, but also avoid a series of stress reactions. It provides favorable conditions for the stability of patients' physiological function and recovery of their body after operation.
Although multimodal analgesia has largely replaced monotherapy with opioids, they are still the most commonly used drugs for postoperative pain. Lidocaine is an amide local anesthetic which when used intravenously demonstrates significant analgesic, anti-hyperalgesic and anti-inflammatory properties .
Intravenous infusion of lidocaine has a good effect on fibromyalgia, chronic neuropathic pain, opioid tolerance and other chronic pain, and can reduce postoperative acute pain. In the 1960s, Barlett et al. first published a study on the use of lidocaine intravenous infusion for postoperative analgesia.Since then, more and more researchers have begun to explore the use of lidocaine in the treatment of postoperative acute pain.In 2007, Kaba et al. selected patients who underwent colectomy as an experimental subject, and intravenously injected lidocaine during the perioperative period. The results showed that the pain of the experimental group was effectively relieved and the use of opioids was reduced. In 2008, Lauwick et al. used laparoscopic cholecystectomy as the experimental subject. The results showed that the dose of opioid analgesia in the lidocaine group was significantly lower than that in the control group, and the postoperative pain was effectively improved. In 2009, Yardeni et al. selected patients undergoing total hysterectomy as experimental subjects and intravenously injected lidocaine during the perioperative period. The results confirmed that the hemodynamics of the experimental group was more stable, the average dosage of anesthetics was reduced, and the pain was significantly improved.However, to date, there is no strong evidence for the effect of perioperative intravenous infusion of lidocaine in single-port thoracoscopic surgery, so we designed this study.
Studientyp
Studientyp
Einschreibung (Voraussichtlich)
Einschreibung
Phase
Phase
- Phase 4
Kontakte und Standorte
Studienkontakt
Studienkontakt
- Name: Jin Ma
- Telefonnummer: 86+18867539602
- E-Mail: 1241370980@qq.com
Studienorte
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310009
- Rekrutierung
- The Second Affiliated Hospital Zhejiang University School of Medicine
-
Kontakt:
- Jin Ma
- Telefonnummer: 86+18867539602
- E-Mail: 1241370980@qq.com
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Patients undergoing single-port thoracoscopic with a left double lumen bronchial catheter
- Age ≧ 18 years old, ≦70 years old
- Temperature, white blood cells, and hemoglobin were normal before surgery
- Patient informed consent
Exclusion Criteria:
- Patients with a history of surgery within six months
- Patients with dysfunction of heart, liver, kidney, lung, pancreas or other important organs
- American Society of Anesthesiologists (ASA) physical Status classes ≧ Ⅲ
- Allergic to lidocaine
- Bradycardia (heart rate < 60 beats/min) or atrioventricular block
- Mental disorder
- Patients requiring a right double lumen bronchial catheter
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Doppelt
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: Lidocaine group
First group (lidocaine group) will include those who receive a intraoperative lidocaine infusion.Induction bolus dose of 1.5 mg/kg body weight ( 30 minutes before incision)followed by a continous lidocaine infusion of 2mg/kg/h,until 1 hours after skin closure.
|
regimen of lidocaine administration of 1.5 mg/kg, IV bolus, followed by continuous infusion at 2 mg/kg/h
|
|
Placebo-Komparator: Saline group
The second group(saline group) will include those who receive a intraoperative placebo.The same dosage of saline was given according to the same method of administration in the lidocaine group.
|
IV bolus of saline, followed by continuous infusion of saline
|
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Postoperative pain score
Zeitfenster: Immediately postoperation
|
Using Visual Analogue Scales
|
Immediately postoperation
|
|
Postoperative pain score
Zeitfenster: 1 hour postoperation
|
Using Visual Analogue Scales
|
1 hour postoperation
|
|
Postoperative pain score
Zeitfenster: 4 hours postoperation
|
Using Visual Analogue Scales
|
4 hours postoperation
|
|
Postoperative pain score
Zeitfenster: 8 hours postoperation
|
Using Visual Analogue Scales
|
8 hours postoperation
|
|
Postoperative pain score
Zeitfenster: 24 hours postoperation
|
Using Visual Analogue Scales
|
24 hours postoperation
|
|
Postoperative pain score
Zeitfenster: 48 hours postoperation
|
Using Visual Analogue Scales
|
48 hours postoperation
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Opioid requirement
Zeitfenster: Immediately postoperation
|
The dosage of opioids was recorded
|
Immediately postoperation
|
|
Opioid requirement
Zeitfenster: 1 hour postoperation
|
The dosage of opioids was recorded
|
1 hour postoperation
|
|
Opioid requirement
Zeitfenster: 4 hours postoperation
|
The dosage of opioids was recorded
|
4 hours postoperation
|
|
Opioid requirement
Zeitfenster: 8 hours postoperation
|
The dosage of opioids was recorded
|
8 hours postoperation
|
|
Opioid requirement
Zeitfenster: 24 hours postoperation
|
The dosage of opioids was recorded
|
24 hours postoperation
|
|
Opioid requirement
Zeitfenster: 48 hours postoperation
|
The dosage of opioids was recorded
|
48 hours postoperation
|
|
Pressing times of PCIA postoperation
Zeitfenster: 48 hours postoperation
|
The pressing times of PCIA within 48 hours postoperation was recorded
|
48 hours postoperation
|
|
Occurrence of nausea and/or vomiting
Zeitfenster: 48 hours postoperation
|
The occurrence of nausea and vomiting within 48 hours postoperation was recorded
|
48 hours postoperation
|
|
Blood level of adrenaline
Zeitfenster: before induction
|
Perioperative blood level of adrenaline was recorded
|
before induction
|
|
Blood level of adrenaline
Zeitfenster: after incision
|
Perioperative blood level of adrenaline was recorded
|
after incision
|
|
Blood level of adrenaline
Zeitfenster: immediately after extubation
|
Perioperative blood level of adrenaline was recorded
|
immediately after extubation
|
|
Blood level of norepinephrine
Zeitfenster: before induction
|
Perioperative blood level of norepinephrine was recorded
|
before induction
|
|
Blood level of norepinephrine
Zeitfenster: after incision
|
Perioperative blood level of norepinephrine was recorded
|
after incision
|
|
Blood level of norepinephrine
Zeitfenster: immediately after extubation
|
Perioperative blood level of norepinephrine was recorded
|
immediately after extubation
|
|
Blood level of adrenocortical
Zeitfenster: before induction
|
Perioperative blood level of adrenocortical was recorded
|
before induction
|
|
Blood level of adrenocortical
Zeitfenster: after incision
|
Perioperative blood level of adrenocortical was recorded
|
after incision
|
|
Blood level of adrenocortical
Zeitfenster: immediately after extubation
|
Perioperative blood level of adrenocortical was recorded
|
immediately after extubation
|
|
Blood level of TNF-alpha
Zeitfenster: before induction
|
Perioperative blood level of TNF-alpha was recorded
|
before induction
|
|
Blood level of TNF-alpha
Zeitfenster: after incision
|
Perioperative blood level of TNF-alpha was recorded
|
after incision
|
|
Blood level of TNF-alpha
Zeitfenster: immediately after extubation
|
Perioperative blood level of TNF-alpha was recorded
|
immediately after extubation
|
|
Blood level of IL-6
Zeitfenster: before induction
|
Perioperative blood level of IL-6 was recorded
|
before induction
|
|
Blood level of IL-6
Zeitfenster: after incision
|
Perioperative blood level of IL-6 was recorded
|
after incision
|
|
Blood level of IL-6
Zeitfenster: immediately after extubation
|
Perioperative blood level of IL-6 was recorded
|
immediately after extubation
|
|
Blood level of IL-10
Zeitfenster: before induction
|
Perioperative blood level of IL-10 was recorded
|
before induction
|
|
Blood level of IL-10
Zeitfenster: after incision
|
Perioperative blood level of IL-10 was recorded
|
after incision
|
|
Blood level of IL-10
Zeitfenster: immediately after extubation
|
Perioperative blood level of IL-10 was recorded
|
immediately after extubation
|
|
Duration of hospital stay
Zeitfenster: from day of surgery until day of discharge from hospital
|
length of hospital stay (in days)
|
from day of surgery until day of discharge from hospital
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Ermittler
Ermittler
- Studienstuhl: Congcong Chen, Second Affiliated Hospital, School of Medicine, Zhejiang University
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Lauwick S, Kim DJ, Michelagnoli G, Mistraletti G, Feldman L, Fried G, Carli F. Intraoperative infusion of lidocaine reduces postoperative fentanyl requirements in patients undergoing laparoscopic cholecystectomy. Can J Anaesth. 2008 Nov;55(11):754-60. doi: 10.1007/BF03016348.
- Kaba A, Laurent SR, Detroz BJ, Sessler DI, Durieux ME, Lamy ML, Joris JL. Intravenous lidocaine infusion facilitates acute rehabilitation after laparoscopic colectomy. Anesthesiology. 2007 Jan;106(1):11-8; discussion 5-6. doi: 10.1097/00000542-200701000-00007.
- Koppert W, Weigand M, Neumann F, Sittl R, Schuettler J, Schmelz M, Hering W. Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg. 2004 Apr;98(4):1050-1055. doi: 10.1213/01.ANE.0000104582.71710.EE.
- Yardeni IZ, Beilin B, Mayburd E, Levinson Y, Bessler H. The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg. 2009 Nov;109(5):1464-9. doi: 10.1213/ANE.0b013e3181bab1bd.
- Schafranski MD, Malucelli T, Machado F, Takeshi H, Kaiber F, Schmidt C, Harth F. Intravenous lidocaine for fibromyalgia syndrome: an open trial. Clin Rheumatol. 2009 Jul;28(7):853-5. doi: 10.1007/s10067-009-1137-8. Epub 2009 Mar 5.
- Challapalli V, Tremont-Lukats IW, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD003345. doi: 10.1002/14651858.CD003345.pub2.
- Buchanan DD, J MacIvor F. A role for intravenous lidocaine in severe cancer-related neuropathic pain at the end-of-life. Support Care Cancer. 2010 Jul;18(7):899-901. doi: 10.1007/s00520-010-0864-3. Epub 2010 Apr 29.
- Sharma S, Rajagopal MR, Palat G, Singh C, Haji AG, Jain D. A phase II pilot study to evaluate use of intravenous lidocaine for opioid-refractory pain in cancer patients. J Pain Symptom Manage. 2009 Jan;37(1):85-93. doi: 10.1016/j.jpainsymman.2007.12.023. Epub 2008 Jul 2.
- Eriksson AS, Sinclair R, Cassuto J, Thomsen P. Influence of lidocaine on leukocyte function in the surgical wound. Anesthesiology. 1992 Jul;77(1):74-8. doi: 10.1097/00000542-199207000-00011.
- Feng G, Liu S, Wang GL, Liu GJ. Lidocaine attenuates lipopolysaccharide-induced acute lung injury through inhibiting NF-kappaB activation. Pharmacology. 2008;81(1):32-40. doi: 10.1159/000107792. Epub 2007 Sep 4.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Voraussichtlich)
Studienbeginn
Primärer Abschluss (Voraussichtlich)
Primärer Abschluss
Studienabschluss (Voraussichtlich)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Physiologische Wirkungen von Arzneimitteln
- Molekulare Mechanismen der pharmakologischen Wirkung
- Anti-Arrhythmie-Mittel
- Depressiva des zentralen Nervensystems
- Agenten des peripheren Nervensystems
- Agenten des sensorischen Systems
- Anästhetika
- Membrantransportmodulatoren
- Anästhetika, lokal
- Spannungsgesteuerte Natriumkanalblocker
- Natriumkanalblocker
- Lidocain
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- 2019-084
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .